Brain Cancer News and Research

There are two main types of brain cancer. Primary brain cancer starts in the brain. Metastatic brain cancer starts somewhere else in the body and moves to the brain. Brain tumors can be benign, with no cancer cells, or malignant, with cancer cells that grow quickly. Also called glioma, meningioma.

Prolonged exposure to formaldehyde linked with increased risk of myeloid leukemia

21. November 2009 00:45

Long durations of exposure to formaldehyde used for embalming in the funeral industry were associated with an increased risk of death from myeloid leukemia, according to a new study published online November 20 in the Journal of the National Cancer Institute. [More]

35e495fd-98b7-493d-b8a4-f4170faa0512|0|.0

Posted in: Medical Condition News

Tags: Brain, Brain Cancer, Cancer, Formaldehyde, Genetics, Leukaemia, Leukemia, Myeloid Leukemia

US and European market for radiopharmaceuticals continues to gain momentum

20. November 2009 02:41

Research and Markets (http://www.researchandmarkets.com/research/410c60/radiopharmaceutica) has announced the addition of the "Radiopharmaceuticals - A US and European Market Analysis" report to their offering. [More]

695b9412-1af5-4d8a-a9fc-d0801585eab5|0|.0

Posted in: Pharmaceutical News

Tags: Antibody, Brain, Brain Cancer, Cancer, Cell, Ciprofloxacin, Follicular Lymphoma, Lung Cancer, Lymphoma, Nephrology, Neurology, Nuclear Medicine, Oncology, Radiation Therapy, Radiotherapy, Zevalin

EIN News launches "Mesothelioma News Today"

19. November 2009 07:27

EIN News, an online leader in industry news monitoring and press syndication, has today added a new publication to its portfolio of health-related international news sites for industry professionals and analysts: Mesothelioma News Today (http://mesothelioma.einnews.com). [More]

e4a30e03-1f98-42de-a60f-7dbd9e8d9458|1|5.0

Posted in: Device / Technology News | Medical Condition News

Tags: Brain, Brain Cancer, Breast Cancer, Cancer, Lung Cancer, Mesothelioma, Prostate Cancer

World's first intra-arterial cerebral infusion of Avastin directly into a patient's malignant brain tumor

18. November 2009 04:43

Neurosurgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center performed the world's first intra-arterial cerebral infusion of Avastin (bevacizumab) directly into a patient's malignant brain tumor. This novel intra-arterial (IA) technique may expose the cancer to higher doses of the drug therapy, while possibly sparing the patient common side effects of receiving the drug intravenously (IV) or throughout their body. [More]

50d53b19-1261-4af8-9034-c4c1c09f6f70|0|.0

Posted in: Medical Procedure News | Medical Condition News

Tags: Avastin, Bevacizumab, Biopsy, Blood Vessel, Bone, Bone Marrow, Brain, Brain Cancer, Brain Tumor, Cancer, Cervical Cancer, Deep Brain Stimulation, Drug Delivery, Education, Gene Therapy, Glioblastoma, Glioblastoma Multiforme, Hospital, Neurology, Oncology, Parkinson's Disease, Penicillin, Pregnancy, Radiology, Spine

Protox Therapeutics announces financial results for the third quarter ended September 30, 2009

16. November 2009 07:42

Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced financial results for the third quarter, ended September 30, 2009. [More]

d199703d-3001-4c8a-b37c-c4dec8a9536b|0|.0

Posted in: Business / Finance

Tags: Benign Prostatic Hyperplasia, Brain, Brain Cancer, Cancer, Exercise, Investment, Prostate Cancer, Sexual Dysfunction

NIH offers $1.6 million, three-year grant to Prism Clinical Imaging

16. November 2009 07:28

Prism Clinical Imaging, Inc., in collaboration with investigators at The Medical College of Wisconsin in Milwaukee, has received a $1.6 million, three-year grant from the National Institutes of Health (NIH) to develop and clinically validate advanced medical imaging software that aids the diagnosis and treatment of patients with brain cancer. [More]

e5dd6c74-93bf-4475-a88b-df95bf6b1892|0|.0

Posted in: Device / Technology News | Medical Condition News

Tags: Brain, Brain Cancer, Brain Tumor, Cancer, Hospital, Pathology, Radiology

Bradmer Pharmaceuticals reports financial results for the third quarter of 2009

12. November 2009 07:37

Bradmer Pharmaceuticals Inc. today announced its 2009 third quarter financial results. [More]

9c9d14cd-4d06-4fde-a4ff-b50dd53d872a|0|.0

Posted in: Business / Finance

Tags: Brain, Brain Cancer, Cancer, Glioblastoma, Glioblastoma Multiforme, Investment

First evidence-based, multidisciplinary treatment guidelines for brain metastases patients to be published

11. November 2009 05:59

Anthony Asher, MD, FACS, of Carolina Neurosurgery & Spine Associates in Charlotte, NC, has co-authored the first evidence-based, multidisciplinary treatment guidelines for brain metastases patients. These guidelines were recently presented at the Congress of Neurological Surgeons 2009 Annual Meeting in New Orleans, and were developed over the last year by a 20-member panel from various medical specialties. [More]

a7ea62a0-3111-4aaf-a0e3-8dd52cdbc176|0|.0

Posted in: Medical Condition News | Healthcare News

Tags: Brain, Brain Cancer, Brain Tumor, Cancer, Education, Hospital, Neurosurgery, Oncology, Spine

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

11. November 2009 01:51

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures. [More]

1b5117db-1e00-402b-9f30-3052db1f8ace|2|5.0

Posted in: Medical Science News | Medical Condition News

Tags: Antibody, Brain, Brain Cancer, Brain Tumor, Breast Cancer, Cancer, Chemotherapy, Glioblastoma, Lung Cancer, Macrophage, Pharmacology, Radiation Therapy, Radiotherapy

Future for magnetic nanoparticles appears even brighter

6. November 2009 03:38

Whether it's magnetic nanoparticles (mNPs) giving an army of 'therapeutically armed' white blood cells direction to invade a deadly tumour's territory, or the use of mNPs to target specific nerve channels and induce nerve-led behaviour (such as the life-dependant thumping of our hearts), mNPs have come a long way in the past decade. [More]

abfa50a0-300e-498b-a575-e93be6947ea6|0|.0

Posted in: Device / Technology News | Medical Science News | Medical Condition News

Tags: Brain, Brain Cancer, Cancer, Cell, Hospital, Nanotechnology

FDA approves SPA Protocol Amendment for Lucanix Phase III clinical trial

4. November 2009 05:46

NovaRx Corporation announced today that the Company has successfully negotiated and received FDA approval for a Special Protocol Assessment (SPA) Protocol Amendment to the pivotal Lucanix® Phase III clinical trial in patients with Non-Small Cell Lung Cancer (NSCLC). [More]

7a86e368-11fa-4c0a-ab61-b39e6bc759d5|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Brain, Brain Cancer, Cancer, Cell, Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Vaccine

Varian Medical Systems to showcase future technologies for managing cancer at the ASTRO

29. October 2009 09:25

New technology enhancements from Varian Medical Systems, designed to make radiotherapy and radiosurgery treatments faster, more accurate, and easier to plan and deliver, will be on display at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Chicago next week. [More]

5bf3df34-3b06-46e9-8f7f-25d9c5fc8775|1|5.0

Posted in: Device / Technology News

Tags: Brachytherapy, Brain, Brain Cancer, Cancer, Oncology, Radiotherapy, Spine

Protox Therapeutics to present Phase 2 study data of PRX302 for benign prostatic hyperplasia

29. October 2009 07:52

Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that detailed data from its open-label Phase 2 clinical study of PRX302 in patients with moderate to severe benign prostatic hyperplasia (BPH) will be presented at the 30th World Congress of the Société Internationale d'Urologie Conference. [More]

93d8fb42-05f8-43e0-85b4-baa69de12606|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Benign Prostatic Hyperplasia, Brain, Brain Cancer, Cancer, Cell, Incontinence, Prostate Cancer, Prostate-Specific Antigen, Sexual Dysfunction

ImmunoCellular Therapeutics presents additional data from its ICT-107 Phase I clinical trial

27. October 2009 09:16

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, today announced additional data from its Phase I clinical trial evaluating ICT-107, the Company’s dendritic-cell based cancer vaccine product candidate for the treatment of glioblastoma multiforme (GBM). [More]

dc23cffb-f9c3-46cb-8c3f-165c24fb1fa7|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Antibody, Biotechnology, Brain, Brain Cancer, Cancer, Cell, Chemotherapy, Dendritic Cell, Glioblastoma, Glioblastoma Multiforme, Immunization, Immunotherapy, Lung Cancer, Monoclonal Antibody, Multiple Myeloma, Oncology, Ovarian Cancer, Pancreatic Cancer, Temozolomide, Vaccine

Results from Phase I dose-escalation study of AT-101 announced

26. October 2009 08:37

Ascenta Therapeutics announced today that encouraging results from a Phase I dose-escalation study of two combination therapy regimens containing AT-101, an oral, pan-Bcl-2 inhibitor, in patients with the most malignant type of brain tumor, were described in an oral presentation at the 2009 Joint Meeting of the Society for NeuroOncology (SNO) and AANS/CNS Section on Tumors in New Orleans, Louisiana (Concurrent Session VI: Radiation Oncology, October 23, 2009; Abstract # 449). [More]

b8c503cd-454d-4414-9a18-dc2e6293d8fb|1|3.0

Posted in: Drug Trial News | Medical Condition News

Tags: Adjuvant Therapy, Apoptosis, Brain, Brain Cancer, Brain Tumor, Cancer, Cell, Chemotherapy, Glioblastoma, Glioblastoma Multiforme, Oncology, Prostate Cancer, Radiation Therapy, Temozolomide

<< Previous posts

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

Free!

Recent Comments

Twitter

Information

Brain Cancer News and Research

Prolonged exposure to formaldehyde linked with increased risk of myeloid leukemia

US and European market for radiopharmaceuticals continues to gain momentum

EIN News launches "Mesothelioma News Today"

World's first intra-arterial cerebral infusion of Avastin directly into a patient's malignant brain tumor

Protox Therapeutics announces financial results for the third quarter ended September 30, 2009

NIH offers $1.6 million, three-year grant to Prism Clinical Imaging

Bradmer Pharmaceuticals reports financial results for the third quarter of 2009

First evidence-based, multidisciplinary treatment guidelines for brain metastases patients to be published

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Future for magnetic nanoparticles appears even brighter

FDA approves SPA Protocol Amendment for Lucanix Phase III clinical trial

Varian Medical Systems to showcase future technologies for managing cancer at the ASTRO

Protox Therapeutics to present Phase 2 study data of PRX302 for benign prostatic hyperplasia

ImmunoCellular Therapeutics presents additional data from its ICT-107 Phase I clinical trial

Results from Phase I dose-escalation study of AT-101 announced

Recent Articles

Free!

Recent Comments

Twitter

Information

Brain Cancer News and Research

Medical News Cloud

Recent Articles